Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -7.19 % |
3 Month Return | + 27.19 % |
1 Year Return | + 86.05 % |
Market Stats | |
Previous Close | ₹8.00 |
Open | ₹8.19 |
Volume | 4.34L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹137.79Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹137.79 Cr |
P/B Ratio | 1.21 |
EPS | 0 |
Dividend Yield | 0 |
Sector | FMCG |
ROE | 5.12 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹137.79 Cr | 68.89% | 0.53 | NA | NA | |
NA | ₹60.12 Cr | -6.76% | 0.79 | NA | NA | |
NA | ₹8.06 Cr | -12.42% | 0.62 | NA | NA | |
NA | ₹84.23 Cr | -0.26% | 0.81 | NA | NA | |
NA | ₹1,296.23 Cr | 54.49% | 0.52 | ₹53 Cr | ₹517 Cr |
Organisation | Ajooni Biotech Ltd |
Headquarters | Mohali |
Industry | FMCG |
E-voting on shares | Click here to vote |
Key events for Ajooni Biotech Ltd
Ajooni Biotech aims to commence commercial production of Moringa by FY 2025-26. The company's ongoing rights-issue aims to raise Rs 43.81 crore, which will be directed towards further research on Moringa's applications in animal health and the establishment of large-scale cultivation infrastructure.
Ajooni Biotech Launches Rights Issue to Raise Rs 43.81 Crore - 22 May, 2024
Animal healthcare solutions firm Ajooni Biotech has launched a rights issue to raise Rs 43.81 crore from existing shareholders. The funds will be used for site development, acquisition of plant and machinery, working capital requirements, and corporate purposes.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Up
Promoters have increased holdings from 26.44% to 26.89% in Jun 2024 quarter
Best in 1 Year
In the last 1 year, AJOONI has outperformed top 5 stocks with highest market-cap in Fishing & Farming
Against Peers
In the last 3 years, Kaveri Seed Company Ltd has given 72.9% return, outperforming this stock by 109.7%
Retail Holding Down
Retail Investor have decreased holdings from 73.56% to 73.11% in Jun 2024 quarter
Price Dip
In the last 7 days, AJOONI stock has moved down by -6.0%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 26.89% | 1.73 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 73.11% | ||
Others | 0% | 0.00 |
Ajooni Biotech Ltd’s net profit jumped 17.5% since last year same period to ₹0.47Cr in the Q1 2024-2025. On a quarterly growth basis, Ajooni Biotech Ltd has generated -48.35% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Ajooni Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.
Ajooni Biotech Ltd (AJOONI) share price today is ₹7.83
Ajooni Biotech Ltd is listed on NSE
Ajooni Biotech Ltd is not listed on BSE
Today’s traded volume of Ajooni Biotech Ltd(AJOONI) is 4.34L.
Today’s market capitalisation of Ajooni Biotech Ltd(AJOONI) is ₹137.79Cr.
Ajooni Biotech Ltd(AJOONI | Price |
---|---|
52 Week High | ₹10.34 |
52 Week Low | ₹3.46 |
Ajooni Biotech Ltd(AJOONI) share price is ₹7.83. It is down -24.27% from its 52 Week High price of ₹10.34
Ajooni Biotech Ltd(AJOONI) share price is ₹7.83. It is up 126.30% from its 52 Week Low price of ₹3.46
Ajooni Biotech Ltd(AJOONI | Returns |
---|---|
1 Day Returns | -0.17% |
1 Month Returns | -7.19% |
3 Month Returns | 27.19% |
1 Year Returns | 86.05% |